In another study, patients with amnestic mild cognitive impairment or Alzheimer's disease who lacked IL-33 expression showed severe cognitive impairment, whereas patients who presented the IL-33 expression maintained their cognitive performance [49]. This evidence concerns the gene IL33 and Alzheimer disease.